An interventional study of Motivational Psychotherapy in Depression and Low Academic Self-Concept, sponsored by Atefe Momeni. Completed at 1 site in Iran. Open to female participants aged 13 Years to 17 Years. Per ClinicalTrials.gov, last updated 2025-07-31.
Sponsored by Atefe Momeni · Not applicable, Interventional, and Treatment
This pilot study investigates the effectiveness of Motivational Psychotherapy in reducing symptoms of depression and improving academic self-concept among adolescent girls in Iran. A total of 30 participants aged 13 to 17 were randomly assigned to an experimental group receiving Motivational Psychotherapy and a control group receiving no treatment. The intervention consisted of 8 weekly sessions based on the principles of motivational interviewing and was tailored to adolescent needs. Outcomes were measured using the Beck Depression Inventory-II (BDI-II) and the Academic Self-Concept Questionnaire (ASCQ). Results suggest the potential benefit of this culturally sensitive approach in non-Western adolescent populations.
This randomized controlled pilot trial evaluated the effectiveness of Motivational Psychotherapy in reducing depressive symptoms and improving academic self-concept among adolescent girls in Iran. A total of 30 participants aged 13-17 years were randomly assigned to either the Motivational Psychotherapy group or a no-intervention control group.
The intervention consisted of 8 weekly individual sessions (60 minutes each) based on a manualized Motivational Psychotherapy protocol, adapted for adolescents in a non-Western context. The sessions focused on resolving ambivalence, enhancing intrinsic motivation, and strengthening environmental support.
Outcome measures included the Beck Depression Inventory-II (BDI-II) for depressive symptoms and the Academic Self-Concept Questionnaire (ASCQ) for academic self-concept. Data were analyzed using ANCOVA to control for baseline differences between groups. The results showed significant improvement in depression scores and academic self-concept in the intervention group compared to the control group, supporting the feasibility and cultural relevance of Motivational Psychotherapy for adolescent mental health.
8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.
This study's enrollment of 30 is below the median of 84 across 6,720 interventional studies indexed under Depression.
Browse Depression studies →This is the only study on the registry with Atefe Momeni as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:
Exclusion Criteria:
Exclusion Criteria:
-
Participants receive Motivational Psychotherapy intervention.
Behavioral: Motivational Psychotherapy
Participants receive no psychological intervention during the study period.
A structured short-term intervention based on motivational psychotherapy, delivered in individual sessions over 8 weeks to improve adolescent depression and academic self-concept.
Change in Depression Score from Baseline to 8 Weeks Post-Intervention
Depression symptoms will be assessed using the Beck Depression Inventory-II (BDI-II; range 0-63, higher scores indicate worse depression). The mean change in BDI-II scores from baseline to 8 weeks will be analyzed between the Motivational Psychotherapy and control groups.
Time frame: Baseline and 8 weeks after start of intervention
Change in Depression Score from Baseline to 8 Weeks Post-Intervention
Depression symptoms will be assessed using the Beck Depression Inventory-II (BDI-II). The primary outcome is the mean change in BDI-II scores from baseline to 8 weeks after the intervention. The comparison will be made between the experimental group (receiving motivational psychotherapy) and the control group.
Time frame: Baseline and 8 weeks after start of intervention
Plan to share: No
This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.